We are inviting Nurses to participate in our new market research study on the topic of cancer immunotherapies. The study will comprise of WATI only, led by a professional moderator experienced in medical issues. To apply please log in or sign up below
We are inviting physicians, primary decision-makers for patients diagnosed with soft tissue sarcoma to take part in our latest market research study. The study will comprise a pre-task and a WATI. To participate, please log in or sign up below.
We are conducting a market research on behalf of a pharmaceutical company and are inviting Oncologists from the UK to take part and share their expert opinion on Metastatic HER2+ Breast Cancer. The purpose of this research is to evaluate perceptions of the existing and future treatment landscape and it will take the form of a 60-minute web-assisted telephone interview. To take part in this important research, please log in or sign up below.
Field Scope International is conducting a new market research study and looking for Haematologists, Haemato-Oncologists, and Oncologists to share their experience on Diffuse Large B Cell Lymphoma Treatment.
Please login or sign up below to participate.
We are looking to speak to physicians, nurses and pharmacists, as we currently conducting a market research study on obesity on behalf of a pharmaceutical company. The purpose of this research is to understand the current management and treatment of people with obesity. To take part in this important study, please log in or sign up below.
We are inviting lab managers or directors and scientists of all levels to take part in our latest market research on Cell Line Authentication (CLA). The overall goal of this research is to better understand the usage and unmet needs of current and potential CLA users to gain important customer insights to help generate a successful marketing campaign and product portfolio that could compete against key competitors. To take part in this important study, please log in or sign up below.
Ponosni članovi i nosioci: